AI Science Tracker
EN

A learned RNA score associates with survival in archived bladder-cancer data

Wenzhou Medical University; Zhejiang University · 31 May 2024 · medicine

Discovery

A learned RNA score associates with survival in archived bladder-cancer data

Source check: Source checked. Not independent scientific confirmation.

Finding: A ten-RNA LASSO score separated overall-survival groups in archived bladder-cancer data. The internal validation subset reported one-, two- and three-year AUCs of 0.663, 0.624 and 0.630. This is a retrospective association with outcome-informed screening, not a verified immunotherapy-response test.

Technology: LASSO

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
LASSO fitted the ten-RNA survival signature after univariate outcome screening, enabling the represented score-to-recorded-survival comparison.
Test and result
The TCGA analysis split 406 cases into 204 training and 202 validation records after prognostic screening; cohort-specific median scores defined high and low groups.
Limitation / still unknown
Outcome screening preceded the split, so the validation subset is not untouched. The separate 65-case local series is stated as collected in 2022–2023 yet reports three-year AUCs in a May 2024 article; that timeline is unresolved and its performance is excluded here. Cohort counts vary between 412 and 406. Treatment-response proxies, drug predictions and proposed molecular mechanisms are not validated clinical outcomes.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11168393/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC11168393/unicode

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary computational Methods on score construction and cohort data; Results on TCGA survival; no experimental protocol review.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 1/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.